Disc Medicine secures $200M in debt financing from Hercules Capital

seekingalpha

2024-11-09

Disc Medicine (NASDAQ:IRON) has obtained a $200M non-dilute term loan facility from Hercules Capital (NYSE:HTGC).
Funding can support development across the portfolio, including the potential accelerated approval pathway for bitopertin in EPP.
The loan facility consists of up to four tranches, three of which can be drawn at Disc’s option and each maturing in November 2029.
An initial $30M tranche was funded at closing, with an additional $80M available to be drawn at Disc’s option. An additional $65M is available subject to Disc's achievement of specified performance milestones. The final $25M tranche is available for draw, at Disc’s option and subject to Hercules consent, during the interest-only period.
Shares of Disc Medicine rose 3% on Friday.
Source: Press Release

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2482676481"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2482676481\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2482676481?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-09 00:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2482676481","market":"us","top_or_hot":-1,"title":"Disc Medicine secures $200M in debt financing from Hercules Capital","media":"seekingalpha","content":"<html><body><ul> <li><a href=\"https://laohu8.com/S/IRON\">Disc Medicine</a> (<span>NASDAQ:IRON</span>) has obtained a $200M non-dilute term loan facility from Hercules Capital (<span>NYSE:HTGC</span>). </li> <li>Funding can support development across the portfolio, including the potential accelerated approval pathway for bitopertin in EPP.</li> <li>The loan facility consists of up to four<span> tranches, three of which can be drawn at Disc’s option and each maturing in November 2029.</span> </li> <li>An initial $30M tranche was funded at closing, with an additional $80M available to be drawn at Disc’s option. An additional $65M is available subject to Disc's achievement of specified performance milestones. The final $25M tranche is available for draw, at Disc’s option and subject to Hercules consent, during the interest-only period.</li> <li>Shares of Disc Medicine rose 3% on Friday. </li> <li>Source: Press Release </li> </ul> </body></html>","source":"seekingalpha_trending_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Disc Medicine secures $200M in debt financing from Hercules Capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDisc Medicine secures $200M in debt financing from Hercules Capital\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">seekingalpha</strong><span class=\"h-time small\">2024-11-09 00:25</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><ul> <li><a href=\"https://laohu8.com/S/IRON\">Disc Medicine</a> (<span>NASDAQ:IRON</span>) has obtained a $200M non-dilute term loan facility from Hercules Capital (<span>NYSE:HTGC</span>). </li> <li>Funding can support development across the portfolio, including the potential accelerated approval pathway for bitopertin in EPP.</li> <li>The loan facility consists of up to four<span> tranches, three of which can be drawn at Disc’s option and each maturing in November 2029.</span> </li> <li>An initial $30M tranche was funded at closing, with an additional $80M available to be drawn at Disc’s option. An additional $65M is available subject to Disc's achievement of specified performance milestones. The final $25M tranche is available for draw, at Disc’s option and subject to Hercules consent, during the interest-only period.</li> <li>Shares of Disc Medicine rose 3% on Friday. </li> <li>Source: Press Release </li> </ul> </body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://seekingalpha.com/news/4266732-disc-medicine-secures-200-m-in-debt-financing-from-hercules-capital\">seekingalpha</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4135","symbol_name":"資產管理與託管銀行","start_time":0,"source_url":"https://seekingalpha.com/news/4266732-disc-medicine-secures-200-m-in-debt-financing-from-hercules-capital","article_id":"2482676481","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2482676481","pubTimestamp":1731083156,"columns":[],"sourceInfo":{"source_id":"seekingalpha_trending_news","name":"Seeking Alpha Trending News"},"weMediaInfo":null,"summary":"Disc Medicine  has obtained a $200M non-dilute term loan facility from Hercules Capital .  Funding can support development across the portfolio, including the potential accelerated approval pathway for bitopertin in EPP. The loan facility consists of up to four tranches, three of which can be drawn at Disc’s option and each maturing in November 2029.  An initial $30M tranche was funded at closing, with an additional $80M available to be drawn at Disc’s option. An additional $65M is available subject to Disc's achievement of specified performance milestones. The final $25M tranche is available for draw, at Disc’s option and subject to Hercules consent, during the interest-only period. Shares of Disc Medicine rose 3% on Friday.  Source: Press Release","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4135":"资产管理与托管银行","IRON":"Disc Medicine","HTGC":"海格投资","BK4139":"生物科技"},"translate_title":"Disc Medicine从Hercules Capital获得2亿美元债务融资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HTGC":1,"IRON":1},"content_text":"Disc Medicine (NASDAQ:IRON) has obtained a $200M non-dilute term loan facility from Hercules Capital (NYSE:HTGC).  Funding can support development across the portfolio, including the potential accelerated approval pathway for bitopertin in EPP. The loan facility consists of up to four tranches, three of which can be drawn at Disc’s option and each maturing in November 2029.  An initial $30M tranche was funded at closing, with an additional $80M available to be drawn at Disc’s option. An additional $65M is available subject to Disc's achievement of specified performance milestones. The final $25M tranche is available for draw, at Disc’s option and subject to Hercules consent, during the interest-only period. Shares of Disc Medicine rose 3% on Friday.  Source: Press Release","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}